These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1419823)

  • 1. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
    Ajzner E; Schlammadinger A; Kerényi A; Bereczky Z; Katona E; Haramura G; Boda Z; Muszbek L
    Blood; 2009 Jan; 113(3):723-5. PubMed ID: 18955560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
    Sosa R; Gailani D; Neff AT
    Haemophilia; 2014 Nov; 20(6):e429-32. PubMed ID: 25333572
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
    Ishida F; Okubo K; Ito T; Okumura N; Souri M; Ichinose A
    Thromb Haemost; 2010 Dec; 104(6):1284-5. PubMed ID: 20941461
    [No Abstract]   [Full Text] [Related]  

  • 6. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescent spot test for coagulation factor XIII.
    Coggan M; Board PG
    Anal Biochem; 1984 Mar; 137(2):402-4. PubMed ID: 6731823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups.
    Girolami A; Burul A; Fabris F; Cappellato G; Betterle C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):131-41. PubMed ID: 77814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration.
    Nishida Y; Ikematsu S; Fukutake K; Fujimaki M; Fukutake K; Kakishita E
    Thromb Res; 1984 Oct; 36(2):123-31. PubMed ID: 6506032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.
    Ichinose A; Souri M;
    Thromb Haemost; 2011 May; 105(5):925-7. PubMed ID: 21264450
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].
    Egbring R; Andrassy K; Havemann K; Fuchs G; Ruf B; Schander K; Trobisch H
    Blut; 1976 Dec; 33(6):367-76. PubMed ID: 1000087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
    Ueno S; Nozaki J; Kusano S; Kawano Y; Kikukawa Y; Okuno Y; Hata H; Matsuoka M; Uchiba M
    Rinsho Ketsueki; 2019; 60(10):1443-1448. PubMed ID: 31695005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.
    Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and classification of factor XIII deficiencies.
    Kohler HP; Ichinose A; Seitz R; Ariens RA; Muszbek L;
    J Thromb Haemost; 2011 Jul; 9(7):1404-6. PubMed ID: 22946956
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.